title: What defines latent infection with Mycobacterium tuberculosis in patients with autoimmune diseases?
authors.affiliation: Department of Transplant and Infection Immunology, Saarland University, Homburg, Germany.
authors.forename: Martina
authors.initials: M
authors.lastname: Sester
authors.affiliation: Department of Paediatrics, Imperial College, London, UK Vaccines & Immunity Theme MRC Unit, The Gambia.
authors.forename: Beate
authors.initials: B
authors.lastname: Kampmann
mesh_terms: D001327:Autoimmune Diseases / Q000188:drug therapy* / Q000276:immunology*; D018450:Disease Progression; D006801:Humans; D016867:Immunocompromised Host; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D055985:Latent Tuberculosis / Q000175:diagnosis* / Q000276:immunology* / Q000382:microbiology / Q000517:prevention & control; D009169:Mycobacterium tuberculosis / Q000276:immunology
chemical_list: D007166:Immunosuppressive Agents
keywords: Tuberculosis